Planning ahead: could a simple program transform Parkinson's care?

NCT ID NCT05954013

First seen Aug 14, 2026 ยท Last updated Aug 14, 2026

Summary

This trial tests a program called PD_Pal, where a specially trained nurse helps people with Parkinson's and their family caregivers create a personalized care plan. The plan covers current care, future needs, and end-of-life preferences, aiming to ensure that care matches what the person wants. The study compares this approach to usual care across seven European countries, measuring whether more participants have their care preferences documented in medical records after six months. It also looks at quality of life, care coordination, and cost-effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
PD_Pal intervention: a nurse-led program combining advance care planning conversations and care coordination, supported by a Parkinson Support Plan workbook
What this could lead to
If effective, this program could become a standard way to help people with Parkinson's and their families plan future care, improving quality of life and ensuring care matches personal preferences.
What could go wrong
The trial is relatively small and open-label, so results may be influenced by expectations. The intervention's success depends on nurse training and patient engagement, which may vary across countries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Estonian Movement Disorders Society

    Tartu, Estonia

  • Paracelsus Medical University

    Salzburg, Austria

  • Philipps University Marburg Medical Center

    Marburg, Germany

  • Skane University Hospital

    Lund, Sweden

  • University College, London

    London, United Kingdom

  • University of Ioannina

    Ioannina, Greece

  • University of Padova

    Padova, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.